Saul Centers Inc
F:SA4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Saul Centers Inc
F:SA4
|
US |
|
A
|
Abbott Laboratories
F:ABL
|
US |
|
B
|
Biomarin Pharmaceutical Inc
XMUN:BM8
|
US |
|
C
|
Cushman & Wakefield PLC
F:2IY
|
UK |
|
H
|
Henry Schein Inc
XMUN:HS2
|
US |
|
S
|
Steel Dynamics Inc
F:SD5
|
US |
|
A
|
Alpha Services and Holdings SA
DUS:ACBB
|
GR |
|
P
|
Panasonic Holdings Corp
XMUN:MAT1
|
JP |
|
Sibanye Stillwater Ltd
F:47V
|
ZA |
|
J
|
Jones Lang LaSalle Inc
F:4J2
|
US |
|
V
|
Ventas Inc
F:VEN
|
US |
|
Aflac Inc
NYSE:AFL
|
US |
|
N
|
NN Group NV
F:2NN
|
NL |
|
Olin Corp
NYSE:OLN
|
US |
Wall St Price Targets
SA4 Price Targets Summary
Saul Centers Inc
According to Wall Street analysts, the average 1-year price target for SA4 is 37.43 EUR with a low forecast of 34.08 EUR and a high forecast of 41.63 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SA4's stock price target?
Price Target
37.43
EUR
According to Wall Street analysts, the average 1-year price target for SA4 is 37.43 EUR with a low forecast of 34.08 EUR and a high forecast of 41.63 EUR.
What is the Revenue forecast for Saul Centers Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 6%.
What is the Net Income forecast for Saul Centers Inc?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 3 years is 29%.
